Cota Healthcare, founded with a mission to revolutionize cancer treatment, focuses on delivering precision medicine at scale through advanced data and technology solutions. The company offers a range of products and services, including Focus Vantage, Vista Clinicogenomics, and Real-World Analytics, aimed at R&D, regulatory, commercial, and healthcare teams. Their market focus is on cancer centers and oncologists, providing real-world insights and support to enhance cancer care.
Notable affiliations include collaborations with Baptist Health South Florida and PreciseDx on AI-enabled breast cancer recurrence risk assessment. Cota's key achievements include significant advancements in real-world evidence utilization to improve patient outcomes. The overall impact of Cota Healthcare lies in its ability to integrate comprehensive data solutions into clinical practice, thereby advancing the field of precision oncology.
